PabloLeitzmanMD(He/Him)
Internal Medicine • Saint Paul, MNHospital Medicine/Hospitalist
Staff Nocturnist
Dr. Leitzman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
640 Jackson St
Saint Paul, MN 55101
Education & Training
Tulane UniversityResidency, Internal Medicine, 2019 - 2022
University of Minnesota Medical SchoolClass of 2019
Certifications & Licensure
MN State Medical License 2022 - 2025
WI State Medical License 2022 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsOral Dosing of Dihydromethysticin Ahead of Tobacco Carcinogen NNK Effectively Prevents Lung Tumorigenesis in A/J MiceQi Hu, Pedro Corral, Sreekanth C. Narayanapillai, Pablo Leitzman, Pramod Upadhyaya
Chemical Research in Toxicology. 2020-07-20 - 12 citationsPilot in Vivo Structure–Activity Relationship of Dihydromethysticin in Blocking 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone-Induced O6-Methylguanine and Lung Tumor ...Manohar Puppala, Sreekanth C. Narayanapillai, Pablo Leitzman, Haifeng Sun, Pramod Upadhyaya
Journal of Medicinal Chemistry. 2017-09-13 - 13 citationsGene expression signatures associated with suppression of TRAMP prostate carcinogenesis by a kavalactone-rich Kava fraction.Su-Ni Tang, Jinhui Zhang, Peixin Jiang, Palika Datta, Pablo Leitzman
Molecular Carcinogenesis. 2016-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
